Raymond James Financial
PULM icon

Raymond James Financial’s Pulmatrix PULM Stock Holding History

Raymond James Financial’s Portfolio PULM Stock Details PULM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1
Closed -$7 – 6313
2025
Q2 		$7 Buy
+1
New +$7 ﹤0.01% 6947

Other funds holding PULM

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Raymond James Financial's PULM Position: Q3 2025 in Review

Raymond James Financial sold out of Pulmatrix (PULM) in Q3 2025, closing a stake of 1 share — an estimated $7 sold.

Raymond James Financial first reported a position in PULM in Q2 2025 and held it in 1 quarter. The position peaked at $7 in Q2 2025. 14 funds tracked by Wall St. Rank hold PULM as of Q3 2025.

  • Raymond James Financial reported no remaining Pulmatrix position as of Q3 2025 after selling out during the quarter.
  • Raymond James Financial sold 1 Pulmatrix share in Q3 2025, an estimated $7.
  • Raymond James Financial first reported a position in Pulmatrix in Q2 2025 and held it in 1 quarter.
  • Raymond James Financial's Pulmatrix position peaked at $7 in Q2 2025.
  • 14 funds tracked by Wall St. Rank held Pulmatrix as of Q3 2025.

Based on Raymond James Financial's 13F filing for Q3 2025, filed 14 Nov 2025.